Health · India

Centre restricts promotion of GLP-1 weight-loss drugs

The Centre has imposed stricter regulations on the promotion of GLP-1 drugs, commonly used for weight loss. These measures include a ban on surrogate advertising and other indirect promotional tactics. The move aims to curb misleading or unsubstantiated claims about the efficacy and safety of these medications. The specific directives are intended to ensure responsible marketing practices for these widely used drugs.

How outlets across the spectrum covered it

Left 0 · Centre 1 · Right 1   n = 2

More balanced coverage on Paksh →